|
1
|
Klein R, Klein BE and Moss SE: The
wisconsin epidemiologic study of diabetic retinopathy: An update.
Arch Ophthalmol. 113:702–703. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Vilsbøll T, Bain SC, Leiter LA, Lingvay I,
Matthews D, Simó R, Helmark IC, Wijayasinghe N and Larsen M:
Semaglutide, reduction in glycated haemoglobin and the risk of
diabetic retinopathy. Diabetes Obes Metab. 20:889–897.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bressler SB, Beaulieu WT, Glassman AR,
Gross JG, Jampol LM, Melia M, Peters MA and Rauser ME: Diabetic
Retinopathy Clinical Research Network: Factors associated with
worsening proliferative diabetic retinopathy in eyes treated with
panretinal photocoagulation or ranibizumab. Ophthalmology.
124:431–439. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kwon JW, Jee D and La TY: Neovascular
glaucoma after vitrectomy in patients with proliferative diabetic
retinopathy. Medicine (Baltimore). 96(e6263)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
de Barros Garcia JMB, Isaac DLC and Avila
M: Diabetic retinopathy and OCT angiography: Clinical findings and
future perspectives. Int J Retina Vitreous. 3(14)2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhu L, Xu J, Liu Y, Gong T, Liu J, Huang
Q, Fischbach S, Zou W and Xiao X: Prion protein is essential for
diabetic retinopathy-associated neovascularization. Angiogenesis.
21:767–775. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lai X, Lili LV and Huang Z: Computerized
diabetic retinopathy diagnosis with optimized random forest. J Med
Imaging Health Inf. 9:274–283. 2019. View Article : Google Scholar
|
|
8
|
Reilly SM and Saltiel AR: Adapting to
obesity with adipose tissue inflammation. Nat Rev Endocrinol.
13:633–643. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen YS: Clinical investigation about the
relationship between visfatin, SAA and type 2 diabetic retinopathy.
Int J Ophthalmol. 12:39–42. 2012. View Article : Google Scholar
|
|
10
|
Mayer-Davis EJ, Davis C, Saadine J,
D'Agostino RB Jr, Dabelea D, Dolan L, Garg S, Lawrence JM, Pihoker
C, Rodriguez BL, et al: Diabetic retinopathy in the SEARCH for
diabetes in youth cohort: A pilot study. Diabet Med. 29:1148–1152.
2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Shen J, Shen S, Das UN and Xu G: Effect of
essential fatty acids on glucose-induced cytotoxicity to retinal
vascular endothelial cells. Lipids Health Dis. 11(90)2012.
View Article : Google Scholar
|
|
12
|
Qu S, Mo L, Niu Y, Sun X, Li H, Wang Z, Xu
W and Rong A: Expression of visfatin in the diabetic rat retina.
Clin Exp Ophthalmol. 44:251–259. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zheng P, Yin Z, Wu Y, Xu Y, Luo Y and
Zhang TC: LncRNA HOTAIR promotes cell migration and invasion by
regulating MKL1 via inhibition miR206 expression in HeLa cells.
Cell Commun Signal. 16(5)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Rong LQ, Mei LJ, Yong C, Xie XQ, Xiong XX,
Qiu XY, Pan F, Liu D, Yu SB and Chen XQ: Piperlongumine inhibits
migration of glioblastoma cells via activation of ROS-dependent p38
and JNK signaling pathways. Oxid Med Cell Longev.
2014(653732)2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Joseph EW, Pratilas CA, Poulikakos PI,
Tadi M, Wang W, Taylor BS, Halilovic E, Persaud Y, Xing F, Viale A,
et al: The RAF inhibitor PLX4032 inhibits ERK signaling and tumor
cell proliferation in a V600E BRAF-selective manner. Proc Natl Acad
Sci USA. 107:14903–14908. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Uslu S, Kebapçi N, Kara M and Bal C:
Relationship between adipocytokines and cardiovascular risk factors
in patients with type 2 diabetes mellitus. ExpTher Med. 4:113–120.
2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Scanlon PH: Diabetic retinopathy.
Medicine. 38:656–660. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Azeze TK, Sisay MM and Zeleke EG:
Incidence of diabetes retinopathy and determinants of time to
diabetes retinopathy among diabetes patients at tikur anbessa
hospital, ethiopia: A retrospective follow up study. BMC Res Notes.
11(542)2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Maimaiti NG and Tuhuti A: Changes of serum
inflammatory factors, adipokines and oxidative stress in patients
with diabetic retinopathy. J Hainan Med Univ. 23:2048–2051. 2017.
View Article : Google Scholar
|
|
20
|
Ludwig PE, Freeman SC and Janot AC: Novel
stem cell and gene therapy in diabetic retinopathy, age related
macular degeneration, and retinitis pigmentosa. Int J Retina
Vitreous. 5(7)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ahmed MB, Ismail MI and Meki AR: Relation
of osteoprotegerin, visfatin and ghrelin to metabolic syndrome in
type 2 diabetic patients. Int J Health Sci (Qassim). 9:127–139.
2015.PubMed/NCBI
|
|
22
|
Yoshida S, Murata M, Noda K, Matsuda T,
Saito M, Saito W, Kanda A and Ishida S: Proteolytic cleavage of
vascular adhesion protein-1 induced by vascular endothelial growth
factor in retinal capillary endothelial cells. Jpn J Ophthalmol.
62:256–264. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kim BS, Yang SS, You HK, Shin HI and Lee
J: Fucoidan-induced osteogenic differentiation promotes
angiogenesis by inducing vascular endothelial growth factor
secretion and accelerates bone repair. J Tissue Eng Regen Med.
12(e1311-e1324)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bhattacharya R, Fan F, Wang R, Ye X, Xia
L, Boulbes D and Ellis LM: Intracrine VEGF signalling mediates
colorectal cancer cell migration and invasion. Br J Cancer.
117:848–855. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tzeng HE, Chen PC, Lin KW, Lin CY, Tsai
CH, Han SM, Teng CL, Hwang WL, Wang SW and Tang CH: Basic
fibroblast growth factor induces VEGF expression in chondrosarcoma
cells and subsequently promotes endothelial progenitor cell-primed
angiogenesis. Clin Sci (Lond). 129:147–158. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Fahey E and Doyle SL: IL-1 family cytokine
regulation of vascular permeability and angiogenesis. Front
Immunol. 10(1426)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kurihara T: Roles of hypoxia response in
retinal development and pathophysiology. Keio J Med. 67:1–9.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Xiao J, Xiao ZJ, Liu ZG, Gong HY, Yuan Q,
Wang S, Li YJ and Jiang DJ: Involvement of dimethylarginine
dimethylaminohydrolase-2 in visfatin-enhanced angiogenic function
of endothelial cells. Diabetes Metab Res Rev. 25:242–249.
2009.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Adya R, Tan BK Punn A, Chen J and Randeva
HS: Visfatin induces human endothelial VEGF and MMP-2/9 production
via MAPK and PI3K/Akt signalling pathways: Novel insights into
visfatin-induced angiogenesis. Cardiovasc Res. 78:356–365.
2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kim SR, Bae SK, Choi KS, Park SY, Jun HO,
Lee JY, Jang HO, Yun I, Yoon KH, Kim YJ, et al: Visfatin promotes
angiogenesis by activation of extracellular signal-regulated kinase
1/2. Biochem Biophys Res Commun. 357:150–156. 2007.PubMed/NCBI View Article : Google Scholar
|
